{"name":"Chengappa, K.N. Roy, MD","slug":"chengappa-k-n-roy-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Active JNJ Drug","genericName":"Active JNJ Drug","slug":"active-jnj-drug","indication":"Metastatic non-small cell lung cancer, PD-L1 positive","status":"phase_2"}]}],"pipeline":[{"name":"Active JNJ Drug","genericName":"Active JNJ Drug","slug":"active-jnj-drug","phase":"phase_2","mechanism":"Active JNJ drug is a monoclonal antibody that targets a specific molecular target.","indications":["Metastatic non-small cell lung cancer, PD-L1 positive"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFAwMy1hM0kyN1ZwMTdtTjc2R2h5M1JLTnJfdmdQMTBkV3pDeXVYZlRPNXZpczgycUh1U3ZRdnNNalZvS3pIakpSZHpNak5KRWxoR0RycjZaTnFvamNfLUdOblJIWG9DYV84T1E?oc=5","date":"2025-04-01","type":"pipeline","source":"Psychiatry Online","summary":"A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now - Psychiatry Online","headline":"A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5XRV9rU1pGOUtKamU3TGdYQWVwaGhzWXhZZVJ0d0Z3azNkS2U3UGd6ZFpBV3c3Mkk2RzBnSUR3QkpjaGtDRkQ2WTEwd19MOGYyYWF4eFBTWDV0b21xQV9yejFTN29tYkQ4N1E?oc=5","date":"2024-07-09","type":"pipeline","source":"Psychiatry Online","summary":"Surviving Manic Depression: A Manual on Bipolar Disorder for Patients, Families, and Providers - Psychiatry Online","headline":"Surviving Manic Depression: A Manual on Bipolar Disorder for Patients, Families, and Providers","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}